Manufacturers Life Insurance Company, The Esperion Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 67,223 shares of ESPR stock, worth $111,590. This represents 0.0% of its overall portfolio holdings.
Number of Shares
67,223
Previous 69,696
3.55%
Holding current value
$111,590
Previous $114,000
28.95%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding ESPR
# of Institutions
215Shares Held
129MCall Options Held
1.78MPut Options Held
1.27M-
Wasatch Advisors Inc Salt Lake City, UT24.5MShares$40.6 Million0.27% of portfolio
-
Black Rock Inc. New York, NY14MShares$23.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$19.4 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.94MShares$16.5 Million0.44% of portfolio
-
Morgan Stanley New York, NY6.31MShares$10.5 Million0.0% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $110M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...